Skip to main content

Want a detailed portfolio tracker?

Moderna (MRNA) P/E (2018 - 2026)

Moderna (MRNA) P/E from Dec 31, 2018 to Jul 20, 2026. The TTM Moderna (MRNA) P/E is -7.33. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Moderna (MRNA)

YearP/EChange
2026-7.33+80.00%
2025-4.07-9.20%
2024-4.49-58.77%
2023-10.88-278.86%
20226.08-27.53%
20218.40-115.32%
2020-54.81+334.04%
2019-12.63-64.43%
2018-35.50N/A

Comparison Moderna (MRNA) P/E with competitors

Moderna (MRNA) P/E is -7.33.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.06%
ENLVEnlivex Ltd0.07-101.02%
FGENFibroGen Inc0.24-103.27%
CHRSCoherus Biosciences Inc0.85-111.57%
FBIOFortress Biotech Inc0.95-112.94%
ORMPOramed Pharmaceuticals Inc1.50-120.49%
AGENAgenus Inc3.01-141.04%
INVAInnoviva Inc3.15-143.00%
VXRTVaxart Inc3.55-148.40%
CRMDCorMedix Inc3.63-149.47%
CVACCureVac N.V.4.45-160.62%
GLPGGalapagos NV4.86-166.25%
SRPTSarepta Therapeutics Inc4.88-166.57%
ABEOAbeona Therapeutics Inc5.39-173.46%
ABUSArbutus Biopharma Corp5.60-176.30%
ZVRAZevra Therapeutics Inc5.89-180.27%
SPROSpero Therapeutics Inc6.23-184.92%
CGENCompugen Ltd6.31-186.09%
RIGLRigel Pharmaceuticals6.87-193.70%
SLXNSilexion Therapeutics Corp7.30-199.48%
OMEROmeros Corporation9.26-226.24%
AUPHAurinia Pharmaceuticals Inc9.58-230.69%
PLXProtalix BioTherapeutics Inc10.89-248.50%
ACADAcadia Pharmaceuticals Inc11.73-259.92%
TBPHTheravance Biopharma Inc12.26-267.19%
ADMAAdma Biologics Inc12.42-269.32%
HRMYHarmony Biosciences Holdings Inc13.82-288.44%
SABSSAB Biotherapeutics Inc14.14-292.74%
NAGENiagen Bioscience Inc14.82-302.04%
INCYIncyte Corp15.82-315.74%
REGNRegeneron Pharmaceuticals Inc15.86-316.20%
PBYIPuma Biotechnology Inc17.32-336.10%
CPRXCatalyst Pharmaceuticals Inc17.44-337.78%
EXELExelixis Inc17.54-339.13%
TGTXTG Therapeutics Inc18.97-358.60%
MDXGMimedx Group Inc20.55-380.23%
XOMAXOMA Royalty Corp22.87-411.90%
ARGXArgen X SE24.30-431.31%
CTMXCytomX Therapeutics Inc24.82-438.44%
XOMAOXOMA Royalty Corp25.34-445.58%
HALOHalozyme Therapeutics Inc25.62-449.38%
XOMAPXOMA Royalty Corp25.67-450.02%
VRTXVertex Pharmaceuticals Inc27.99-481.71%
RPRXRoyalty Pharma plc - Class A28.69-491.16%
SLNOSoleno Therapeutics Inc29.02-495.63%
ASNDAscendis Pharma A/S30.09-510.22%
LGNDLigand Pharmaceuticals Inc - Class B37.91-616.94%
APLSApellis Pharmaceuticals Inc39.02-632.06%
BMRNBiomarin Pharmaceutical Inc42.21-675.57%
KRYSKrystal Biotech Inc45.34-718.27%
ONCBeiGene Ltd69.54-1048.20%
PHARPharming Group N.V.75.03-1122.99%
TECHBio-Techne Corp101.96-1490.22%
VCELVericel Corp109.92-1598.80%
ALNYAlnylam Pharmaceuticals Inc117.96-1708.48%
GMABGenmab140.29-2012.89%
TLXTelix Pharmaceuticals Ltd162.15-2310.99%
CORTCorcept Therapeutics Inc212.86-3002.36%